Eek— that’s gross! New Yorkers can get hantavirus from rats scurrying around the city — but only if you’re doing something ...

Completed Phase 1b studies for ABI-5366 and ABI-1179, helicase-primase inhibitors for recurrent genital herpes - ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today ...

Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

Some viruses are known to increase the risk of cancer over time. This article highlights six major viruses and explains how ...

In this study, researchers investigated the potential impacts of “shared decision-making” replacing universal HBV birth-dose vaccination on neonatal and later chronic HBV infections.

Hepatitis C is known as a “silent” virus that may not be detected until the slow but progressive and potentially ...

Gen X made it through the ’80s — from cassette tapes to dial-up to VHS — but one thing they couldn’t leave behind? The virus ...